Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raija Ristamäki

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|August 4, 2016
[Principles of oncologic drug therapy following surgery for bowel cancer]Raija Ristamäki, Annika Ålgars
Duodecim; Laaketieteellinen Aikakauskirja|May 19, 2016
[Drug therapy of advanced pancreatic neuroendocrine tumor]Raija Ristamäki, Maija Tarkkanen
Duodecim; Laaketieteellinen Aikakauskirja|August 4, 2016
[Streamlined treatment pathway for a colorectal cancer patient]Arto Rantala, Raija Ristamäki, Ulla Keränen
Duodecim; Laaketieteellinen Aikakauskirja|December 4, 2010
[Changing prognosis and treatment of gastric cancer]Raija Ristamäki, Paulina Salminen, Arto Kokkola, et al.
Oncology Reports|October 25, 2008
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancerRiyad Bendardaf, Hanan Lamlum, Raija Ristamäki, et al.
Scandinavian Journal of Gastroenterology|September 14, 2007
MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastasesRiyad Bendardaf, Abdelbaset Buhmeida, Raija Ristamäki, et al.
Journal of Gastrointestinal Cancer|February 24, 2017
Overall Survival and Metastasis Resections in Patients with Metastatic Colorectal Cancer Using Electronic Medical RecordsEetu Heervä, Maija Lavonius, Panu Jaakkola, et al.
Anticancer Research|June 3, 2006
Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinomaAbdelbaset Buhmeida, Annika Algars, Raija Ristamäki, et al.
Surgical Oncology|March 11, 2019
Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathologyHanna Vihervaara, Annika Ålgars, Jukka Kemppainen, et al.
Cancer Research|April 19, 2003
Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck regionSanna-Mari Maula, Marjaana Luukkaa, Reidar Grénman, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Duodecim; Laaketieteellinen Aikakauskirja|August 4, 2016
[Principles of oncologic drug therapy following surgery for bowel cancer]Raija Ristamäki, Annika Ålgars
Duodecim; Laaketieteellinen Aikakauskirja|May 19, 2016
[Drug therapy of advanced pancreatic neuroendocrine tumor]Raija Ristamäki, Maija Tarkkanen
Duodecim; Laaketieteellinen Aikakauskirja|August 4, 2016
[Streamlined treatment pathway for a colorectal cancer patient]Arto Rantala, Raija Ristamäki, Ulla Keränen
Duodecim; Laaketieteellinen Aikakauskirja|December 4, 2010
[Changing prognosis and treatment of gastric cancer]Raija Ristamäki, Paulina Salminen, Arto Kokkola, et al.
Oncology Reports|October 25, 2008
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancerRiyad Bendardaf, Hanan Lamlum, Raija Ristamäki, et al.
Scandinavian Journal of Gastroenterology|September 14, 2007
MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastasesRiyad Bendardaf, Abdelbaset Buhmeida, Raija Ristamäki, et al.
Journal of Gastrointestinal Cancer|February 24, 2017
Overall Survival and Metastasis Resections in Patients with Metastatic Colorectal Cancer Using Electronic Medical RecordsEetu Heervä, Maija Lavonius, Panu Jaakkola, et al.
Anticancer Research|June 3, 2006
Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinomaAbdelbaset Buhmeida, Annika Algars, Raija Ristamäki, et al.
Surgical Oncology|March 11, 2019
Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathologyHanna Vihervaara, Annika Ålgars, Jukka Kemppainen, et al.
Cancer Research|April 19, 2003
Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck regionSanna-Mari Maula, Marjaana Luukkaa, Reidar Grénman, et al.
Pageof 4